The following is a reconciliation of net income and shares outstanding to the net income and number of shares used to compute earnings per share (“EPS”) for the periods indicated:


	For the Three Months Ended
	September 30, 2026			June 30, 2026			September 30, 2025
	Income		Shares	Income		Shares	Income		Shares
	(dollars in thousands except per share data)
Net income	$	12,637		$	10,140		$	10,148
Shares outstanding			16,827,168			16,985,919			17,043,897
Impact of weighting shares			83,284			25,705			181,805
Used in basic EPS	12,637		16,910,452	10,140		17,011,624	10,148		17,225,702
Dilutive effect of outstanding stock options & RSUs			117,234			130,118			75,925
Used in dilutive EPS	$	12,637	17,027,686	$	10,140	17,141,742	$	10,148	17,301,627

Basic earnings per common share	$	0.75		$	0.60		$	0.59
Diluted earnings per common share	$	0.74		$	0.59		$	0.59


	For the Nine Months Ended September 30,
	2026			2025
	Income		Shares	Income		Shares
	(dollars in thousands except per share data)
Net income	$	34,077		$	21,771
Shares outstanding			16,827,168			17,043,897
Impact of weighting shares			167,548			520,938
Used in basic EPS	34,077		16,994,716	21,771		17,564,835
Dilutive effect of outstanding stock options & RSUs			119,397			56,764
Used in dilutive EPS	$	34,077	17,114,113	$	21,771	17,621,599

Basic earnings per common share	$	2.01		$	1.24
Diluted earnings per common share	$	1.99		$	1.24

Options to purchase zero, 12,000, and 34,000 shares of common stock were excluded from the calculation of diluted earnings per share for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively, because their effect would have been anti-dilutive. Options to purchase 13,231 and 82,247 shares of common stock were excluded from the calculation of diluted earnings per share for the nine months ended September 30, 2026 and 2025, respectively, because their effect would have been anti-dilutive. There were 8,226, zero, and 2,300 anti-dilutive unvested RSUs outstanding for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, and 2,772 and 6,786 anti-dilutive unvested RSUs outstanding for the nine months ended September 30, 2026 and 2025.